Newly released internal EPA documents show the agency permitted pesticide giant Bayer to select from a menu of regulation options for the controversial weedkiller dicamba, raising questions about regulatory independence and oversight of destructive agricultural chemicals.
HHS Office of Inspector General audits found that Humana and UnitedHealthcare Medicare Advantage plans exaggerated the health needs of members through upcoding practices, resulting in nearly $180 million in overpayments between 2020 and 2021.
A federal judge paused a lawsuit by Florida and Texas seeking to severely limit nationwide access to the abortion pill mifepristone while the Trump administration completes a review of the drug's approval.
The Michigan Supreme Court ruled 4-3 on July 31, 2026, overturning two lower court decisions and allowing Attorney General Dana Nessel to proceed with an investigation into Eli Lilly's insulin pricing practices under the Michigan Consumer Protection Act.
The Federal Trade Commission, Utah, and Los Angeles County sued telehealth company Hims & Hers Health for allegedly misleading consumers about its products and sharing private health information with advertisers. Shares fell 10% following the announcement.
The Trump administration has paused over $1 billion in federal Medicaid payments to California and Minnesota, with Health Secretary Robert F. Kennedy Jr. citing suspected fraud and noncompliance. The states must provide documentation to receive the withheld funds.
The Trump administration has frozen federal funding for New York's Medicaid Fraud Control Unit, with HHS Inspector General Thomas March Bell citing insufficient criminal indictments as the reason for the suspension.
Family planning and health organizations in Pennsylvania have filed a lawsuit alleging that a new Trump administration policy could delay or deny federal funding to providers serving tens of thousands of patients across the state.
The U.S. Supreme Court ruled 7-2 in favor of Bayer's Monsanto division, blocking thousands of state-level lawsuits alleging the company failed to warn consumers that Roundup weedkiller could cause cancer. The decision establishes that federal pesticide labeling law preempts state liability claims.
The Department of Justice sent letters to Yale School of Medicine and UCLA alleging illegal discrimination against applicants who are not Black or Hispanic in their admissions processes.
A key GOP lawmaker is investigating whether the American Medical Association's medical billing codes are contributing to healthcare fraud, broadening Republican efforts to combat fraud in the healthcare system.
The Supreme Court appeared divided during oral arguments over whether to block thousands of lawsuits alleging that Bayer's Roundup weedkiller failed to warn consumers it could cause cancer, a case with multibillion-dollar implications for the pharmaceutical industry.
CVS Health's Caremark pharmacy benefits unit reached a settlement with the U.S. Federal Trade Commission to curb controversial rebate practices in the pharmacy benefits market. The agreement requires Caremark to count consumer purchases from Trump's TrumpRx program toward insurance deductibles, mirroring a similar settlement previously reached with Cigna.
Jefferson Health filed a lawsuit against Aetna claiming its policy of reducing reimbursement for certain inpatient hospital stays violates federal law and their reimbursement contract. Aetna disputes Jefferson's claims.
The Department of Justice announced three separate civil and criminal actions targeting companies and individuals for schemes that attempted to fraudulently bill taxpayer-funded healthcare programs for approximately $500 million.
The Federal Trade Commission struck a proposed settlement with CVS over charges that its pharmacy benefit manager manipulated insulin prices and impeded patient access. The FTC estimates the settlement will save Americans up to $7 billion in out-of-pocket costs over 10 years.
